Buzz Stocks: Keryx Biopharmaceuticals, SolarCity Corp, and Caesars Entertainment Corp

Today's stocks to watch in the news include Keryx Biopharmaceuticals (NASDAQ:KERX), SolarCity Corp (NASDAQ:SCTY), and Caesars Entertainment Corp (NASDAQ:CZR)

Aug 1, 2016 at 10:19 AM
facebook twitter linkedin

U.S. stocks are down, erasing early gains as the historically bearish month of August begins with a slide in crude oil prices and a round of manufacturing data. Among equities in focus today are biotech Keryx Biopharmaceuticals (NASDAQ:KERX), renewable energy firm SolarCity Corp (NASDAQ:SCTY), and casino stock Caesars Entertainment Corp (NADAQ:CZR).

  • KERX is down 31.4% at $5.07, after production issues for its kidney disease drug, Auryxia -- its only approved drug -- caused the firm to withdraw its 2016 financial guidance. Prior to today's losses, KERX was up 45.7% for 2016, but is now struggling to stay above breakeven year-to-date, and the shares now sit below their 10-week moving average, which had acted as support since early March. While KERX has landed on the short-sale restricted list, there are likely quite a few shorts celebrating this news, with 23.7% of Keryx Biopharmaceuticals' float sold short -- an amount that would take over three weeks of trading to cover, at KERX's average daily volume. 
  • CZR is up 8.6% at $7.49, following the announcement that its online games unit will be sold to a Chinese consortium for $4.4 billion. CZR currently sits up 42.8% year-over-year, and its Schaeffer's Volatility Index (SVI) of 78% sits lower than 91% of all other readings from the past year, indicating that near-term option traders are pricing in relatively low volatility expectations ahead of tomorrow's earnings call. CZR option buyers are likely cheering this latest news, with Caesars Entertainment Corp's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 5.21 sitting in the 91st percentile of its annual range.

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!